This session explores advanced treatment options for lung emphysema, including bronchoscopic and surgical lung volume reduction (BLVR & SLVR). Learn from expert discussions on pathophysiology, patient selection, and the latest innovations to enhance care. Presented by Dr. med. Didier Schneiter (University Hospital Zurich) and Prof. Dr. med. Carolin Steinack (University Hospital Zurich), and moderated by Prof. Dr. med. Servet Bölükbas (University Hospital Essen).
What You’ll Learn
- Expanded Clinical Criteria & Outcomes for LVRS: How a multidisciplinary approach is broadening the indications for Lung Volume Reduction Surgery (LVRS), demonstrating that carefully selected patients can achieve a 68% gain in FEV1 with an acceptable 2.4% surgical mortality rate at six months.
- Evidence-Based Patient Selection Pathways: The critical diagnostic requirements—such as assessing fissure completeness via CT and chartis measurements for collateral ventilation—used by interdisciplinary boards to confidently choose between Bronchoscopic Lung Volume Reduction (BLVR) and surgical non-anatomical resection.
- Procedural Innovations in Fragile Tissue: Real-world procedural insights from the Zurich cohort, including the targeted use of reinforced surgical staplers to minimize early post-operative air leaks, and how endoscopic valve treatments demonstrate strong survival benefits for up to 10 years.
